In the News
Oligopoly - Why is insulin so expensive?
14th February 2019
A fascinating Business Insider clip looking at why insulin is so expensive in the US - and why it hasn't always been that way.
Insulin is an essential drug for diabetics, but the price has increased so dramatically. Why? You would think that the absence of patent protection would reduce the market price of insulin.
Well, insulin is only produced by three firms in the US - who claim to set prices independently - but as a good economist with an understanding of business behaviour in an oligopoly, you might think differently.
This is a fantastic look at the nature of the markets and a really rather worrying clip.
You might also like

Tesco cuts the value of Clubcard rewards scheme
21st March 2023

Monopoly - Eli Lilly cuts prices of insulin by up to 70%
1st March 2023
What is Price Stickiness?
Study Notes
Significance of PED with Indirect Taxes
Topic Videos